logo
logo

Astrazeneca To Acquire Neogene Therapeutics, Accelerating Ambition In Oncology Cell Therapy

Nov 29, 2022•almost 3 years ago

Acquiring Company

British biopharma company

Acquired Company

Neogene Therapeutics

Cambridge

Description

Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T-cell receptor therapies (TCR-Ts), today announced it has entered into a definitive agreement to be acquired by AstraZeneca.

Company Information

Company

British biopharma company

Location

Cambridge, Massachusetts, United States

About

A British biopharmaceutical company focused on developing new therapies and treatments for various diseases. The company is known for its expertise in drug development and innovative approaches to healthcare. It aims to address unmet medical needs through advanced biopharmaceutical solutions. Details on its specific operations or pipeline are not provided in the current context.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed